Curology, a prescription skincare company, has closed $15 million in Series B financing. Advance Vixeid Partners led the round with participation from return backers Sherpa Capital and Forerunner Ventures.
Source: Press Release
Curology, a prescription skincare company, has closed $15 million in Series B financing. Advance Vixeid Partners led the round with participation from return backers Sherpa Capital and Forerunner Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: